I have not seen any thread on this one yet... Good write-up at https://www.copyright link/street-talk/wound-treatment-biotech-tissue-repair-kicks-off-roadshow-20210928-p58vgz
Summary:
Lead managers: Bell Potter and Morgans
Cornerstone investors: Ellerston, Washington H. Soul Pattinson and Australian Unity
Valuation: apparently attractive, comparing to other listed ASX businesses active in this space
Stage of product development: phase three of clinical trials in 2022 (again, among a few only on ASX that reached that stage)
I am in with a spread allocation. The backers, valuation, product and the lead manager (Morgans) drew my interest.
- Forums
- IPOs
- Tissue Repair Ltd (ASX:TRP)
I have not seen any thread on this one yet... Good write-up at...
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online